Skip to content

Bajaj Healthcare successfully completes USFDA pre-approval inspection of Vadodara plant

The US Food and Drug Administration (USFDA) had conducted a pre-approval inspection of the facility from November 14, 2022, to November 17, 2022, Bajaj Healthcare Ltd (BHL) said in a regulatory filing.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish